Concepedia

Natasha Hill

NH

Statistics

Publications

22

Citations

1.5K

H-Index

18

Active since

1995

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Kingston University

Wellcome Trust

University of Cambridge

Centre for Human Genetics

Natasha Hill is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, immunology, and autoimmunity.

ORCID

Top concepts

Publications per year

1995–2020

22

Publications

22

The NOD Idd9 Genetic Interval Influences the Pathogenicity of Insulitis and Contains Molecular Variants of Cd30, Tnfr2, and Cd137

Paul Lyons, Wayne W. Hancock, Paul Denny et al. · Immunity · 2000 · 164 citations · Full text

, , +10

NOD Idd5 locus controls insulitis and diabetes and overlaps the orthologous CTLA4/IDDM12 and NRAMP1 loci in humans.

Natasha Hill, Paul Lyons, N Armitage et al. · Diabetes · 2000 · 154 citations · Full text

, , +19

Congenic Mapping of the Type 1 Diabetes Locus,<i>Idd3</i>, to a 780-kb Region of Mouse Chromosome 3: Identification of a Candidate Segment of Ancestral DNA by Haplotype Mapping

Paul Lyons, N Armitage, Fabio Argentina et al. · Genome Research · 2000 · 138 citations · Full text

Congenic mapping of the insulin-dependent diabetes (Idd) gene, Idd10, localizes two genes mediating the Idd10 effect and eliminates the candidate Fcgr1

Patricia L. Podolin, Paul Denny, Christopher J. Lord et al. · The Journal of Immunology · 1997 · 128 citations

Mapping of the IDDM Locus <i>Idd3</i> to a 0.35-cM Interval Containing the <i>Interleukin-2</i> Gene

Paul Denny, Christopher J. Lord, Natasha Hill et al. · Diabetes · 1997 · 123 citations

, , +19

1–5 of 22